Western virologist hopes to test vaccine on 600 HIV-negative subjects next fall
An HIV vaccine (SAV001) developed at Western University can now move on to Phase II human clinical trials. Plans are underway to test it in 600 HIV-negative subjects across North America as early as next fall. The Phase II trial, once approved by government regulatory agencies, will determine the vaccine’s ability to produce anti-HIV antibodies in patients who are not infected with the virus.
Continue Reading http://mediarelations.uwo.ca
Join the Discussion